{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:12:59Z","timestamp":1792678379642,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY08126"],"award-info":[{"award-number":["EY08126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK59637"],"award-info":[{"award-number":["DK59637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK58404"],"award-info":[{"award-number":["DK58404"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK20593"],"award-info":[{"award-number":["DK20593"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA68485"],"award-info":[{"award-number":["CA68485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["U54HD083211"],"award-info":[{"award-number":["U54HD083211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["HD083181"],"award-info":[{"award-number":["HD083181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001819","name":"RettSyndrome.org","doi-asserted-by":"crossref","award":["#3201"],"award-info":[{"award-number":["#3201"]}],"id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001819","name":"RettSyndrome.org","doi-asserted-by":"crossref","award":["#2906"],"award-info":[{"award-number":["#2906"]}],"id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rett syndrome (RTT) is a neurodevelopmental disorder primarily caused by mutations in Methyl-CpG-binding Protein 2 (MECP2). More than 35% of affected individuals have nonsense mutations in MECP2. For these individuals, nonsense suppression has been suggested as a possible therapeutic approach. To assess the viability of this strategy, we created and characterized a mouse model with the common p.R294X mutation introduced into the endogenous Mecp2 locus (Mecp2R294X). Mecp2R294X mice exhibit phenotypic abnormalities similar to those seen in complete null mouse models; however, these occur at a later time point consistent with the reduced phenotypic severity seen in affected individuals containing this specific mutation. The delayed onset of severe phenotypes is likely due to the presence of truncated MeCP2 in Mecp2R294X mice. Supplying the MECP2 transgene in Mecp2R294X mice rescued phenotypic abnormalities including early death and demonstrated that the presence of truncated MeCP2 in these mice does not interfere with wild-type MeCP2. In vitro treatment of a cell line derived from Mecp2R294X mice with the nonsense suppression agent G418 resulted in full-length MeCP2 protein production, demonstrating feasibility of this therapeutic approach. Intraperitoneal administration of G418 in Mecp2R294X mice was sufficient to elicit full-length MeCP2 protein expression in peripheral tissues. Finally, intracranial ventricular injection of G418 in Mecp2R294X mice induced expression of full-length MeCP2 protein in the mouse brain. These experiments demonstrate that translational read-through drugs are able to suppress the Mecp2 p.R294X mutation in vivo and provide a proof of concept for future preclinical studies of nonsense suppression agents in RTT.<\/jats:p>","DOI":"10.1093\/hmg\/ddaa102","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T19:09:37Z","timestamp":1590606577000},"page":"2461-2470","source":"Crossref","is-referenced-by-count":29,"title":["Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome"],"prefix":"10.1093","volume":"29","author":[{"given":"Jonathan K","family":"Merritt","sequence":"first","affiliation":[{"name":"Department of Neurosciences, University of California at San Diego, La Jolla, CA 92093, USA"},{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37212, USA"},{"name":"Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN 37203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget E","family":"Collins","sequence":"additional","affiliation":[{"name":"Medical Scientist Training Program, Vanderbilt University, Nashville, TN 37232, USA"},{"name":"Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty R","family":"Erickson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37212, USA"},{"name":"Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN 37203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37212, USA"},{"name":"Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN 37203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Neul","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of California at San Diego, La Jolla, CA 92093, USA"},{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37212, USA"},{"name":"Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN 37203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"2020090402222417400_ref1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"2020090402222417400_ref2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/0883073815579707","article-title":"Improving treatment trial outcomes for Rett syndrome: the development of Rett-specific anchors for the clinical global impression scale","volume":"30","author":"Neul","year":"2015","journal-title":"J. Child Neurol."},{"key":"2020090402222417400_ref3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"2020090402222417400_ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.870050303","article-title":"Rett syndrome and associated movement disorders","volume":"5","author":"FitzGerald","year":"1990","journal-title":"Mov. Disord."},{"key":"2020090402222417400_ref5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/088307380101600512","article-title":"Progressive cardiac dysautonomia observed in patients affected by classic Rett syndrome and not in the preserved speech variant","volume":"16","author":"Guideri","year":"2001","journal-title":"J. Child Neurol."},{"key":"2020090402222417400_ref6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.braindev.2018.03.010","article-title":"The course of awake breathing disturbances across the lifespan in Rett syndrome","volume":"40","author":"Tarquinio","year":"2018","journal-title":"Brain Dev."},{"key":"2020090402222417400_ref7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"2020090402222417400_ref8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J. Med. Genet."},{"key":"2020090402222417400_ref9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","article-title":"A double-blind, randomized, placebo-controlled clinical study of Trofinetide in the treatment of Rett syndrome","volume":"76","author":"Glaze","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"2020090402222417400_ref10","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","article-title":"Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome","volume":"92","author":"Glaze","year":"2019","journal-title":"Neurology"},{"key":"2020090402222417400_ref11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"2020090402222417400_ref12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"2020090402222417400_ref13","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J. Neurosci."},{"key":"2020090402222417400_ref14","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2","volume":"104","author":"Giacometti","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2020090402222417400_ref15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/15476286.2015.1068497","article-title":"Translational readthrough potential of natural termination codons in eucaryotes \u2013 the impact of RNA sequence","volume":"12","author":"Dabrowski","year":"2015","journal-title":"RNA Biol."},{"key":"2020090402222417400_ref16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/514620","article-title":"The pharmacodynamics of aminoglycosides","volume":"27","author":"Lacy","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"2020090402222417400_ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(10)78021-6","volume-title":"Methods in Enzymology, Glycomics","author":"Pokrovskaya","year":"2010"},{"key":"2020090402222417400_ref18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J. Med. Chem."},{"key":"2020090402222417400_ref19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"2020090402222417400_ref20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI70462","article-title":"Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects","volume":"124","author":"Gregory-Evans","year":"2014","journal-title":"J. Clin. Invest."},{"key":"2020090402222417400_ref21","doi-asserted-by":"crossref","first-page":"e60478","DOI":"10.1371\/journal.pone.0060478","article-title":"Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression","volume":"8","author":"Keeling","year":"2013","journal-title":"PLoS One"},{"key":"2020090402222417400_ref22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1165\/rcmb.2013-0282OC","article-title":"Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by Ivacaftor","volume":"50","author":"Xue","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2020090402222417400_ref23","doi-asserted-by":"crossref","first-page":"e20733","DOI":"10.1371\/journal.pone.0020733","article-title":"Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations","volume":"6","author":"Vecsler","year":"2011","journal-title":"PLoS One"},{"key":"2020090402222417400_ref24","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/hmg\/ddv030","article-title":"Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene","volume":"24","author":"Pitcher","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2020090402222417400_ref25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J. Mol. Med."},{"key":"2020090402222417400_ref26","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"2020090402222417400_ref27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"2020090402222417400_ref28","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2020090402222417400_ref29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1585183","article-title":"Modality-specific retrograde amnesia of fear","volume":"256","author":"Kim","year":"1992","journal-title":"Science"},{"key":"2020090402222417400_ref30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","article-title":"Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning","volume":"106","author":"Phillips","year":"1992","journal-title":"Behav. Neurosci."},{"key":"2020090402222417400_ref31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/hmg\/ddw074","article-title":"mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome","volume":"25","author":"Gogliotti","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"2020090402222417400_ref32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ng.1066","article-title":"Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome","volume":"44","author":"Samaco","year":"2012","journal-title":"Nat. Genet."},{"key":"2020090402222417400_ref33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.21715","article-title":"Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome","volume":"66","author":"Ramocki","year":"2009","journal-title":"Ann. Neurol."},{"key":"2020090402222417400_ref34","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ymgme.2014.12.026","article-title":"The nonsense suppression drug PTC124 restored alpha-l-iduronidase activity and reduces glycosaminoglycan accumulation in MPS IH mice carrying the Idua-W402X mutation","volume":"114","author":"Bedwell","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"2020090402222417400_ref35","author":"Eloxx Pharmaceuticals, Inc","year":"2017"},{"key":"2020090402222417400_ref36","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/hmg\/ddn062","article-title":"A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome","volume":"17","author":"Samaco","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"2020090402222417400_ref37","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1523\/JNEUROSCI.0057-11.2011","article-title":"MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan","volume":"31","author":"Ward","year":"2011","journal-title":"J. Neurosci."},{"key":"2020090402222417400_ref38","doi-asserted-by":"publisher","first-page":"e3779","DOI":"10.3791\/3779","article-title":"Skin punch biopsy explant culture for derivation of primary human fibroblasts","volume":"77","author":"Vangipuram","year":"2013","journal-title":"J Vis. Exp."},{"key":"2020090402222417400_ref39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1073\/pnas.0809632106","article-title":"Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2\u03b1) dephosphorylation in mammalian development","volume":"106","author":"Harding","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2020090402222417400_ref40","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1073\/pnas.1602049113","article-title":"New inducible genetic method reveals critical roles of GABA in the control of feeding and metabolism","volume":"113","author":"Meng","year":"2016","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddaa102\/33430279\/ddaa102.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/29\/15\/2461\/33711122\/ddaa102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/29\/15\/2461\/33711122\/ddaa102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T14:19:17Z","timestamp":1722953957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/29\/15\/2461\/5848266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":40,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2020,5,29]]},"published-print":{"date-parts":[[2020,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaa102","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,1]]},"published":{"date-parts":[[2020,5,29]]}}}